Lyon CC et al. |
Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. |
1999 |
Br. J. Dermatol. |
pmid:10233300
|
Vente C et al. |
Erosive mucosal lichen planus: response to topical treatment with tacrolimus. |
1999 |
Br. J. Dermatol. |
pmid:10233234
|
Johnston A and Holt DW |
Therapeutic drug monitoring of immunosuppressant drugs. |
1999 |
Br J Clin Pharmacol |
pmid:10233195
|
Uno T et al. |
Pharmacokinetic advantages of a newly developed tacrolimus oil-in-water-type emulsion via the enteral route. |
1999 |
Lipids |
pmid:10230718
|
Göthel SF and Marahiel MA |
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. |
1999 |
Cell. Mol. Life Sci. |
pmid:10228556
|
Torocsik HV et al. |
FK506-induced leukoencephalopathy in children with organ transplants. |
1999 |
Neurology |
pmid:10227644
|
Taylor DO et al. |
A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. |
1999 |
J. Heart Lung Transplant. |
pmid:10226898
|
Charco R et al. |
Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy. |
1999 |
Liver Transpl Surg |
pmid:10226111
|
Herr I et al. |
FK506 prevents stroke-induced generation of ceramide and apoptosis signaling. |
1999 |
Brain Res. |
pmid:10224298
|
Ferrari D et al. |
P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. |
1999 |
J. Biol. Chem. |
pmid:10224077
|
Green MD and Michaels MG |
Tacrolimus: effects and side effects. |
1999 |
Pediatr. Infect. Dis. J. |
pmid:10223694
|
Knoll GA and Bell RC |
Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. |
1999 |
BMJ |
pmid:10213717
|
Jani A et al. |
Modulation of cell-mediated immunity prolongs adenovirus-mediated transgene expression in sciatic nerve. |
1999 |
Hum. Gene Ther. |
pmid:10210146
|
Lütkes P et al. |
[Quality of life following transplantation. The impact ofa new immunosuppressive substance]. |
1999 |
Zentralbl Chir |
pmid:10209841
|
Cetinkale O et al. |
Modulating the functions of neutrophils and lipid peroxidation by FK506 in a rat model of thermal injury. |
1999 |
Burns |
pmid:10208383
|
Hortelano S et al. |
Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages. |
1999 |
Br. J. Pharmacol. |
pmid:10205001
|
Nagasaki Y et al. |
Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer. |
1999 |
Pediatr. Res. |
pmid:10203136
|
Sloper CM et al. |
Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. |
1999 |
Ophthalmology |
pmid:10201592
|
De Lima JJ et al. |
Effects of FK506 in rat and human resistance arteries. |
1999 |
Kidney Int. |
pmid:10201018
|
Mollison KW et al. |
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases. |
1998 |
Curr. Pharm. Des. |
pmid:10197049
|